CoChat

Magnetic Seizure Therapy in Refractory Psychiatric Disorders: A Systematic Review and Meta-Analysis: La thérapie par convulsions magnétiques pour la prise en charge des troubles psychiatriques réfractaires : revue systématique et méta-analyse

Open access

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Objective: To qualitatively and quantitatively synthesize the literature on the efficacy and safety of magnetic seizure therapy (MST) in psychiatric disorders. Methods: A literature search was conducted of the OVID Medline, OVID EMBASE, PsychINFO, CINAHL, Web of Science and Cochrane databases from inception to 14 January 2024, using subject headings and key words for “magnetic seizure therapy.” Randomized controlled trials (RCTs), post-hoc analyses of RCTs, open-label trials, or case series investigating MST in adults with a verified psychiatric diagnosis and reporting on two possible primary outcomes (1) psychiatric symptom reduction (as measured by validated rating scale) or (2) neurocognitive outcomes (as measured by standardized testing), were included. Abstracts, individual case reports, reviews and editorials were excluded. Extracted data included: (1) basic study details; (2) study design; (3) sample size; (4) baseline demographics; (5) outcome data (including secondary outcomes of suicidal ideation and adverse events); and (6) stimulation parameters. Cochrane's risk of bias tool was applied. A quantitative analysis was conducted for the depression studies, using Hedge's g effect sizes. Results: A total of 24 studies (n = 377) were eligible for inclusion. Seventeen studies in depression (including three RCTs), four studies in schizophrenia (including one RCT), one study in bipolar disorder, one study in obsessive-compulsive disorder and one study in borderline personality disorder were summarized. We found no significant difference in depressive symptom reduction between MST and electroconvulsive therapy (ECT) in randomized, controlled trials (g = 0.207 towards ECT, 95% confidence interval (CI) −0.132 to 0.545, P = 0.232). We found a significant reduction in depressive symptoms overall with MST in the pooled RCT and open-label analysis (g = 1.749, CI 1.219 to 2.279, P < 0.005). It is suggested that MST has modest cognitive side effects. Conclusions: Large-scale RCTs are necessary to confirm early signals of MST as an effective intervention in psychiatric disorders with a cognitive profile that is potentially more favourable than ECT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/07067437241301005

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. PRISMA flow diagram.
Figure 1. PRISMA flow diagram.CC BY-NC · PubMed Central
Figure 2. (a) Forest plot of MST versus ECT on depressive symptoms in RCTs. The cumulative effect size across three studies was 0.207 in favour of ECT (95% CI −0.132 to 0.545, Z-value = 1.194, P = 0.232). (b) Forest plot of MST versus ECT on depressive symptoms across RCTs and open-label trials. The cumulative effect size across six studies was −0.068 in favour of MST (95% CI −0.674 to 0.539, Z-value = −0.219, P = 0.827). (c) Forest plot of MST on depressive symptoms across all studies. The pooled effect size across eight studies included was 1.749 (95% CI 1.219 to 2.279, Z-value = 6.740, P < 0.005).
Figure 2. (a) Forest plot of MST versus ECT on depressive symptoms in RCTs. The cumulative effect size across three studies was 0.207 in favour of ECT (95% CI −0.132 to 0.545, Z-value = 1.194, P = 0.232). (b) Forest plot of MST versus ECT on depressive symptoms across RCTs and open-label trials. The cumulative effect size across six studies was −0.068 in favour of MST (95% CI −0.674 to 0.539, Z-value = −0.219, P = 0.827). (c) Forest plot of MST on depressive symptoms across all studies. The pooled effect size across eight studies included was 1.749 (95% CI 1.219 to 2.279, Z-value = 6.740, P < 0.005).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Research works printed but not linked: 1

  1. R: A language and environment for statistical computing. Vienna, Austria: R Core Team. R Foundation for Statistical Computing; 2021.

Cited by

See all 9

Metadata

Authors
Prillo, J., Zapf, L., Espinola, C. W., Daskalakis, Z. J., & Blumberger, D. M.
Affiliations
  • Centre for Addiction and Mental Health (CA)
  • UC San Diego Health System (US)
Corresponding author
Blumberger, Daniel M.
Venue
The Canadian Journal of Psychiatry
Published
2024-12-09
Volume
70
Issue
10
Pages
732-749
ISSN
  • 0706-7437 (ISSN-L)
  • 1497-0015
OpenAlex
W4405214948
Cited by
9
References
64
Citations by year
2026: 8 · 2025: 1
FWCI
0.72
Type
journal article
Language
en
Open access
Licence
Locations
  • The Canadian Journal of Psychiatry (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords
magnetic seizure therapy, refractory psychiatric disorders, depression, schizophrenia, bipolar disorder, obsessive-compulsive disorder, borderline personality disorder, neurocognitive side effects, suicidal ideation, treatment efficacy and safety, stimulation parameters, adverse events, cognitive profile, treatment-resistant depression, treatment-resistant schizophrenia, treatment-resistant bipolar disorder, treatment-resistant OCD
MeSH terms
Mental Disorders, Humans, Outcome Assessment, Health Care, Magnetic Field Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Magnetic Seizure Therapy in Refractory Psychiatric Disorders: A Systematic Review and Meta-Analysis: La thérapie par convulsions magnétiques pour la prise en charge des troubles psychiatriques réfractaires : revue systématique et méta-analyse. https://app.cochat.ai/papers/10.1177/07067437241301005
The paper
Prillo, J., Zapf, L., Espinola, C. W., Daskalakis, Z. J., & Blumberger, D. M. (2025). Magnetic Seizure Therapy in Refractory Psychiatric Disorders: A Systematic Review and Meta-Analysis: La thérapie par convulsions magnétiques pour la prise en charge des troubles psychiatriques réfractaires : revue systématique et méta-analyse. The Canadian Journal of Psychiatry. https://doi.org/10.1177/07067437241301005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.